Iradimed picked up an FDA nod for its MRI-compatible intravenous infusion pump system, which enables patients who can’t be disconnected from IV medication to undergo MRI scanning. The company will now ...

Iradimed Corp () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for ...

Pump shipments again led performance in the quarter as our 3860 MRI IV pump grew another 20% year-over-year in Q3. Our MR monitor sales have also continued to impress. I am also pleased to report that ...

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that ...

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host ...

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief ...

Image source: The Motley Fool. IRadimed Corporation (NASDAQ:IRMD) reported another quarter of record revenue and revealed stronger-than-expected underlying pump and monitoring business demand. The ...